Greenwich LifeSciences Inc. (GLSI)
NASDAQ: GLSIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
GLSI stock chart
Technical analysisKey statistics
All statistics- Market cap
- $225.90M
- EPS (TTM)
- -$1.53
- Dividend yield
- None
- 52-week range
- 7.78 – 34.10
- Day range
- 15.00 – 16.37
- Volume / Avg
- 147.19K / 138.58K
- Beta
- —
- Shares outstanding
- 14.68M
- Next earnings
- Nov 12, 2026
52-week range
GLSI stock today
Greenwich LifeSciences (GLSI) closed at $15.39 on Oct 7, down 2.53% (-$0.40), versus the S&P 500's 0.22% decline. Shares are 54.9% below their 52-week high of $34.10, set on Jan 27, 2026 and 97.8% above the 52-week low of $7.78, in the middle of the past year's range. GLSI is down 26.7% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 37.0%.
Greenwich LifeSciences has posted a net loss over the last twelve months (EPS of -$1.53), so its P/E ratio is not meaningful. Greenwich LifeSciences's next earnings report is expected on Nov 12, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Greenwich LifeSciences
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2020
Earnings
Earnings history- Next report
- Nov 12, 2026
Greenwich LifeSciences peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| EVMNEvommune Inc. | 6.22 | -5.90% | $225.74M | vs GLSI |
| MGNXMacroGenics Inc. | 3.55 | -2.47% | $226.14M | vs GLSI |
| KROSKeros Therapeutics Inc. | 11.21 | +1.82% | $222.26M | vs GLSI |
| IFRXInflaRx N.V. | 1.56 | -1.27% | $229.89M | vs GLSI |
| PRQRProQR Therapeutics N.V. | 1.63 | -1.21% | $230.02M | vs GLSI |
| NATRNature's Sunshine Products Inc. | 12.59 | +0.40% | $221.53M | vs GLSI |
| TRDAEntrada Therapeutics Inc. | 5.61 | +3.51% | $218.43M | vs GLSI |
| SIONSionna Therapeutics Inc. | 4.82 | +1.47% | $217.62M | vs GLSI |
Indexes, lists and sector
Greenwich LifeSciences stock FAQ
What is Greenwich LifeSciences's stock price today?
GLSI last traded at $15.39 as of Oct 7, 4:00 PM EDT, down 2.53% on the day. Prices are delayed at least 15 minutes.
When is Greenwich LifeSciences's next earnings date?
Greenwich LifeSciences is expected to report earnings on Thursday, November 12, 2026.
What is the GLSI 52-week high?
The 52-week high for GLSI is $34.10 and the 52-week low is $7.78. The stock is currently 54.9% below its high.